REGINA, Saskatchewan–(BUSINESS WIRE)–#ACMPR–OneLeaf Cannabis Corp. (the “Company” or “OneLeaf”) is pleased to
announce that its application to become a licensed producer under Health
Canada’s Access to Cannabis for Medical Purpose Regulations (“ACMPR”)
has advanced to “Active Review”, the final stage of the ACMPR
application process that precedes the issuance of a cultivation license.
OneLeaf’s engagement of Cannabis Compliance Inc. (“CCI”) has been
instrumental in helping propel its application to the forefront with
Health Canada, reaching this important milestone in only 5 months after
application submission. “It speaks to the quality of OneLeaf’s
application and management team,” commented Samuel Bouabane, CCI’s
Manager of Cannabis Strategic Licensing.
“CCI has provided sound, strategic advice, as well as expert service
with Health Canada,” commented Mike Templeton, Chief Operating Officer
of OneLeaf. “We look forward to continuing to work closely with CCI and
Health Canada as we complete our state-of-the-art production facility
Update on Construction of OneLeaf-Onyx
OneLeaf commenced construction of OneLeaf Onyx in January, 2018, and is
pleased to announce the 48,200 sq. ft. pre-engineered purpose-built
facility has been erected, with the outershell and insulation slated for
completion in the next 30 days. Phase 1 of the interior buildout, which
is fully funded, will comprise approximately 16,500 sq. ft. and is
anticipated to be completed by the end of this August. Upon completion
of Phase 1, OneLeaf will submit an evidence package to Health Canada
demonstrating its readiness to begin cultivating cannabis.
About OneLeaf Cannabis Corp.
OneLeaf Cannabis Corp. is a Saskatchewan based late-stage Licensed
Producer applicant under the ACMPR, in “Active Review” with Health
Canada. With deep roots in Saskatchewan, the Company looks forward to
contributing to the reputation the Province has earned in producing
premium agricultural products.
OneLeaf Cannabis Corp.
Chief Operating Officer